Abstract Cyclin-dependent kinase (Cdk) 5 is ubiquitously expressed in the brain and plays an essential role in central nervous system development and synaptic plasticity. The p35 kinase is a neuronal specific activator of Cdk5. Here, we show for the first time that Cdk5 activation modulates leptin signaling. P35 and its metabolite p25 were colocalized with the leptin receptor ObR in selective neurons in the hypothalamus. Overexpression of p35 alone was sufficient to induce the transcriptional activation of signal transducer and activator of transcription 3 (STAT3) in a cellular model. In retinoic acid-differentiated SH-SY5Y neuronal cells where ObRb was induced, leptin increased the expression of Cdk5, p35, and p25 kinases. The time course of induction coincided with that of phosphorylated (p)-STAT3. When Cdk5 activity was inhibited, either by roscovitine or overexpression of dominant negative Cdk5, there was a reduction of pSTAT3 activation. The results show that the activation of Cdk5 by p35 sustained leptin-induced pSTAT3 at 3-6 h. Thus, p35 is a novel modulator of leptin-induced STAT3 signaling.
Introduction
It is not uncommon that a polypeptide is named for the effect by which it was discovered, but later found to have a multitude of actions (Kastin et al. 1983 ). Cyclin-dependent kinase (Cdk) 5 is a member of the Cdk family but appears to have unique functions in the central nervous system (CNS) that are independent of cell cycle regulation. Cdk5 is predominantly expressed in the brain. It participates in cognitive functions, learning, and synaptic plasticity (Cheung et al. 2006; Tang et al. 1996) . Mice with Cdk5 deletion have defective brain development (Ohshima et al. 1999) . The level of Cdk5 expression is highest in postmitotic neurons in the developing and adult nervous system, as compared with that in the kidney, testis, and ovary (Lew et al. 1995) . Cdk5 is unique in its family in that it is not activated by cyclins and its activity requires association with one of two brain-specific regulatory subunits termed p35 and p39 (Tsai et al. 1994; Zheng et al. 1998) .
P35 is a neuronal specific activator of Cdk5 that has a short half-life and cell membrane distribution, whereas its caplain-cleaved product p25 has a five-to tenfold longer half-life and is localized diffusely in cells (Patrick et al. 1999) . Conversion of p35 and sustained activation of p25 have been shown to contribute to abnormal tau phosphorylation in Alzheimer's disease (Baumann et al. 1993; Tseng et al. 2002) . Although recent studies clearly indicate interactions between Cdk5 and the signal transducer and activator of transcription 3 (STAT3; Fu et al. 2004; Lin et al. 2007; Wang et al. 2006) , there are no studies showing a direct relationship between the Cdk5 system and leptin signaling.
Leptin is a 16-kD adipokine produced mainly by adipocytes. It has multiple cellular targets in the CNS after crossing the blood-brain barrier (BBB; Banks et al. 1996; Levin et al. 2004; Pan and Kastin 2007a; Pan et al. 2008b) or blood-CSF barrier (Zlokovic et al. 2000) . It may also reach the median eminence of the hypothalamus, a circum-ventricular region lying outside the BBB (Kastin and Pan 2006) . The activation of hypothalamic neurons by leptin is associated with neuronal development and neuroendocrine regulation. Leptin also improves synaptic plasticity and shows anti-epileptic functions (Harvey 2007; Xu et al. 2008) . Although direct activation of cation channels and phosphoinositol-3 kinase (PI3K)-Akt and other signaling pathways have been shown (Guo et al. 2008 ), STAT3 phosphorylation is a predominant means of activation by the long cytoplasmic domain receptor ObRb. Inhibitory signals that counteract this activation include suppressor of cytokine signaling (SOCS-3; Bjorbak et al. 2000; Schwartz et al. 2000; Waelput et al. 2000) and protein-tyrosine phosphatase (PTP1B; Zabolotny et al. 2002) . In obese mice with dysregulation of the leptin system, there are defects in intracellular signaling (Garris 1989; Vaisse et al. 1996) .
Protein sequence analysis indicates that Ser 727 in STAT3 is a typical phosphorylation site for Cdk5. The Cdk5/p35 complex phosphorylates STAT3 at the Ser 727 residue in vitro and in vivo. In muscle of Cdk5-deficient mice, both the DNA-binding activity of STAT3 and the transcription of its downstream target genes are reduced. In macrophages, STAT3 phosphorylation at Ser 727 is essential for its maximal activation (O'Rourke and Shepherd 2002) . These results suggest a physiological role of Cdk5 in regulating STAT3 phosphorylation and modulating its transcriptional activity that can also be tested after leptin stimulation.
Materials and Methods
Cell Culture and Treatment SH-SY5Y human neuroblastoma cells and HEK293 cells (American Type Culture Collection, ATCC, Manassas, VA, USA) were grown in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS). The cells were differentiated by treatment with 10 μM of all-trans retinoic acid (Sigma, St. Louis, MO, USA) between 1 and 6 days after plating. Sixteen hours after serum starvation, the cells were treated with the specific Cdk5 inhibitor roscovitine (30 μM for 15 min pretreatment as well as cotreatment for specified intervals; Sigma) and 30 nM leptin (R & D Systems, Minneapolis, MN, USA) for different time intervals (10 min-6 h), as specified in the "Results" section. The vehicle control for roscovitine was 0.1% DMSO. The zero time group in the roscovitine study was pretreated with roscovitine (30 μM) for 15 min. All cells were plated at the same time, treated according to the time intervals designed for individual experiments, and harvested at the same endpoint. All findings were replicated.
Mouse Models of Obesity C57BL/6J male mice (Jackson Laboratories, Bar Harbor, ME, USA) were used to induce diet-induced obesity (DIO) following a protocol approved by the Institutional Animal Care and Use Committee. Four-week-old mice were grouphoused and randomly assigned to either a high fat diet (HFD, 45% kcal fat; D12451, Research Diets, New Brunswick, NJ, USA) or regular rodent chow for 16 weeks. Body weight was measured weekly after induction of obesity for both the DIO and control groups. The percentage of body fat was determined with a Bruker minispec Live Mice Analyzer (model mq7.5, LF50; Bruker Optics, Inc., Billerica, MA, USA), as described previously (Pan and Kastin 2007b) . The obesity phenotype of A vy mice (Jackson Laboratories) has been characterized previously and studied in parallel with the C57BL/6J littermate controls (Pan et al. 2008a) . After the onset of obesity, these mice were studied along with their respective controls for western blotting in hypothalamic tissue, or immunohistochemistry of ObR and p35, by the use of methods established in our laboratory.
Immunofluorescent Staining
Abiding by animal protocols approved by the Institutional Animal Care and Use Committee, adult male B6 mice or age-matched A vy mice (3-5 months old) were anesthetized by urethane intraperitoneally and perfused intracardially with 30 ml normal saline followed by 4% paraformaldehyde. The brain was post-fixed overnight in 4% paraformaldehyde and cryoprotected in 15% and then 30% sucrose. Coronal hypothalamic sections of 20 μm thickness were obtained by the use of a cryostat. Cultured cells were fixed with 4% paraformaldehyde for 10 min at room temperature. The hypothalamic tissue sections or cells were permeabilized with 0.3% Triton X-100 and blocked with 10% normal donkey serum, incubated with a primary antibody overnight at 4°C. The antibodies include rabbit anti-p35 antibody (1:200-1:100, Santa Cruz Biotechnology sc-820, Santa Cruz, CA, USA) and goat anti-mouse ObR antibody (1:100, Santa Cruz Biotechnology; sc-1834). The p35 antibody also recognizes the shorter fragment p25 that is cleaved from p35 but has a longer half-life, more diffuse subcellular distribution, and probably higher biological activity (Lew et al. 1994) . The ObR antibody is raised against the membrane juxtapositional cytoplasmic domain of mouse ObR short forms and reacts with all membranebound leptin receptor isoforms. After thorough washing, they were incubated with their respective Alexa488-conjugated secondary antibodies for 1 h, washed, and mounted. Negative controls were incubated with a secondary antibody only.
Western Blot Analysis
The cells were lysed in ice-cold RIPA buffer (100 mM NaCl, 10 mM Tris, pH 7.2, 0.1% SDS, 1% Triton X-100, 1% deoxycholate, 5 mM EDTA) in the presence of protease inhibitor cocktail (Pierce, Rockford, IL, USA). The lysates were sonicated and cleared by ultracentrifugation. The protein content was measured by bicinchoninic acid assay (Pierce). Thirty to 50 μg of protein was electrophoresed on 12% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA, USA). The membrane was blocked with 5% non-fat dry milk in Trisbuffered saline (pH 7.6) containing 0.1% Tween-20, and probed with rabbit anti-p35 (polyclonal, 1:200, Santa Cruz Biotechnology, sc-820), mouse anti-Cdk5 (monoclonal, 1:1,000, Upstate; 05-364), rabbit anti-pSer 727 -STAT3 (polyclonal, 1:500, Biosource, 44-384G), rabbit anti-pTyr 705 -STAT3 (polyclonal, 1:100, Santa Cruz Biotechnology, sc-7993-R), rabbit anti-pSOCS-3 (polyclonal, 1:200, Santa Cruz Biotechnology, sc-9023), and mouse anti-β-actin (monoclonal, 1:10,000, Sigma, A2228) overnight at 4°C. After thorough washing, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature. The signals were developed with enhanced chemiluminescence-plus western blotting detection reagents (Amersham Biosciences, Piscataway, NJ, USA). All findings were confirmed in replicate studies.
Plasmids, Transient Transfection, and Luciferase Assay
For luciferase assays, HEK293 cells in 24-well plates were transfected with 0.2 μg/well of pAH-Luc STAT3 luciferase reporter plasmid from Dr. Rosenblum (Rosenblum et al. 1996) and 0.01 μg of phRL-TK (Renilla luciferase) reference plasmid (Promega, Madison, WI, USA) along with the genes of interest. These include empty vector, WTCdk5, DN-Cdk5, ObRb, or p35-pEGFP-C2, according to the group design (n=4/group). The construction of WTCdk5 and DN-Cdk5 from Dr. Wang had been described previously. At 24 h after transfection, the cells were pelleted and lysed with a component from the DualLuciferase Reporter Assay 1000 System kit (Promega). After addition of substrates, the activities of firefly luciferase and Renilla luciferase were measured on a luminometer (20/20 n , Turner Biosystems, Sunnyvale, CA, USA). The luminescent intensity of firefly luciferase was normalized as a ratio to that of Renilla luciferase, as previously described ).
HEK293 cells grown in 24-well plates at 90% confluency were transfected with 1.2 μg of plasmids by the use of Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in serum-free DMEM. Four hours later, the medium was replaced with DMEM with 10% FBS. Differentiated SH-SY5Y cells (90% confluency) were suspended in electroporation buffer provided in the Nucleofector Kit V (Amaxa, Gaithersburg, MD, USA) to a final concentration of 2×10 6 /100 μl after detachment by trypsin. A mixture of 100 μl of cell suspension and 9 μg of plasmids was electronically transfected by the use of the Nucleofector Device (Amaxa) with program G-004. The cells were aliquoted into 24-well plates and cultured in 5% CO 2 at 37°C for another 24 h.
RNA Extraction and RT-PCR
Total RNA was obtained with an Absolutely RNA Miniprep Kit (Stratagene, La Jolla, CA, USA) and reversely transcribed. PCR was performed beginning with a single cycle of 94°C for 2 min, followed by 35 cycles (human ObRb) or 26 cycles (β-actin) of 94°C for 30 s, 56°C 30 s, and 72°C for 30 s. This was followed by a single cycle of 72°C for 10 min to facilitate final extension. The primers for human ObRb were: forward 5′-CCT CTT CCA TCT TAT TGC TTG GA and reverse 5′-CTC AAA CGT TTC TGG CTT CTG AA. The primers for the housekeeping gene β-actin were: forward 5′-GAT CTG GCA CCA CAC CTT CT and reverse 5′-GGG GTG TTG AAG GTC TCA AA. The PCR products were electrophoresed on 2% agarose gel containing ethidium bromide and imaged by the Kodak EDAS290 system.
Statistical Analysis
Data are expressed as means ± standard errors. Significant differences were determined by repeated measures (for body weight) or one-way analysis of variance (for NMR measurement of fat composition and for luciferase reporter assay), followed by Tukey's post hoc test. This was performed by the use of the Statistical Analysis for Social Science software (SPSS Inc, Chicago, IL, USA) and graphed by Prism GraphPad software (San Diego, CA, USA).
Results

P35 Is Present in ObR (+) Neurons in Mouse Hypothalamus
Immunostaining was performed by the use of a polyclonal antibody against the common N-terminal domain of p35 and p25 in hypothalamic sections from adult B6 mice. The negative control group showed no fluorescent signal in the absence of the primary antibody. There were at least two distinctive populations of cells that are p35 (+): neurons that showed cytoplasmic immunoreactivity and tanycytes around the third ventricle and median eminence that showed fibrous staining. Confocal analyses showed that some of the p35 (+) neurons also express the leptin receptor ObR (Fig. 1) . Since leptin activates STAT3 through ObR in neurons, we further determined the interactions between p35-induced Cdk5 activation and STAT3 signaling in cultured cells.
P35 Alone Is Sufficient to Induce Transcriptional Activation of STAT3
The cDNAs of P35, Cdk5, or dominant-negative (DN)-Cdk5 were overexpressed in HEK293 cells along with luciferase reporter genes (n=4/group). A negative control group was transfected with the empty vector along with the luciferase reporters. At 24 h after transfection, the cells were pelleted without treatment, and basal luciferase reporter activity was measured. Despite the absence of ligand stimulation, the groups of cells overexpressing p35 kinase showed a significant elevation of STAT3 luciferase reporter gene activity. This was a dose-dependent effect, as the increase of STAT3 luminescence was significantly higher in the cells transfected with the higher dose (0.4 μg/ml/well) of p35 than with the lower dose (0.3 μg/ml/ well). By contrast, neither the wild-type Cdk5 nor DN-Cdk5 caused a significant change in the minimal activation of STAT3 (Fig. 2) . To determine whether leptin activates p35 current to its induction of STAT3 and thus potentiates STAT3 activity, we treated SH-SY5Y neuroblastoma cells with leptin.
Leptin Induces Cdk5 and Its Activators p35 and p25 by Increasing Their Expression and Causing Subcellular Redistribution Differentiated SH-SY5Y cells represent a suitable cellular model with induced ObRb expression and time-dependent STAT3 after leptin stimulation (Fig. 3a-c) . Cellular staining with a shared antibody against p35 and its smaller fragment p25 showed that leptin (30 nM) induced redistribution of the immunofluorescence within the cells. In the basal state, p35/p25 was clustered in the cytoplasm. At either 1 or 6 h after leptin treatment, there was no apparent increase of fluorescent intensity, but there was a change of subcellular distribution. A more diffuse pattern of p35/25 immunofluorescence was seen (Fig. 4a) . Western blotting further differentiated the p35 and p25 kinases by their sizes. Leptin treatment caused a time-dependent increase of both p35 and p25. Cdk5 itself was also increased. These changes were apparent at 30 min. Cdk5 and p35 reached their peaks by 1 h, while p25 showed a persistent increase at 3 and 6 h (Fig. 4b) . Consistent with reports that p25 has a more diffuse distribution pattern as well as a longer half-life, the results suggest that there was an increase of conversion of p35 to p25 by proteases. The major increase in p25 seen in western blotting was thus consistent with a more diffuse subcellular distribution pattern seen in immunostaining. and S 727 sites between 30 min and 6 h and reduced SOCS-3 expression simultaneously (left panels, Fig. 5 ). When the Cdk5 inhibitor roscovitine (30 μM) was present when the cells were stimulated with leptin, the time course and phosphorylation sites of STAT3 activation both changed. For pSTAT3-Y 705 , the increase at 3 and 6 h was no longer present (top lane). For pSTAT3-S 727 , there appeared to be an early potentiation and later depression by roscovitine. This resulted in a shift of activation to earlier times and reduced pSTAT3 signal at 3 and 6 h (second lane). ) between 30 min and 6 h of treatment; the increase at the later time points (3 and 6 h) was dampened by cotreatment with roscovitine, which also shifted pSTAT3-S 727 activation to an earlier time. The induction of SOCS-3 was greatly diminished by roscovitine, which dampened SOCS-3 signal between 10 min and 6 h Figure 4 Effect of leptin treatment (30 nM) on Cdk5 in SH-SY5Y cells. a Western blotting showed that leptin induced Cdk5, p35, and p25 by 30 min, with peaks at 30 min, 1 h, and 3 h, respectively. The housekeeping gene β-actin was unchanged. b Immunocytochemistry showed that leptin treatment altered the subcellular distribution of p35/ p25 from the cytoplasmic cluster at the basal state to a more diffuse pattern at 1 and 6 h Moreover, roscovitine induced a persistent reduction of SOCS-3 signal (third lane). The expression of the housekeeping gene β-actin was not affected by the treatment.
Inhibition of Endogenous Cdk5 Activity by Dominant Negative Cdk5 (DN-Cdk5) Blocks Leptin-Induced pSTAT3 Upregulation
At 16 h after transfection of the differentiated SH-SY5Y cells with DN-Cdk5 or wild-type (WT)-Cdk5 by electroporation, the cells were treated with leptin (30 nM) for 1, 3, or 6 h, in parallel with the non-treated controls (time 0). Figure 6 shows that leptin treatment in cells overexpressing WT-Cdk5 induced pSTAT3 at both the Y 705 and S 727 sites, without changing the expression of the housekeeping gene β-actin. This increase of pSTAT3 was not seen in the groups of cells overexpressing DN-Cdk5 at any of the time points studied. Surprisingly, WT-Cdk5 reduced SOCS-3 at 1 and 3 h, but increased it at 6 h after leptin treatment.
Increased pSTAT3 Coincides with Elevated p35/p25 in DIO and A vy Mice
Consistent with the increase in immunofluorescent staining of p35/p25 in the arcuate nucleus, DIO mice had increased protein expression of both p35 and p25 in the hypothalamus, although the total amount of Cdk5 remained constant (Fig. 7, left panel) . In A vy mice, the protein level of p35 remained the same while the more active p25 kinase was increased (Fig. 7, right panel) . In both types of obese mice, there was an increase in the level of pSTAT3 in comparison with the lean B6 controls. This leads to the question whether the activation of the Cdk5 system results in STAT3 phosphorylation in neuronal cells. Figure 7 Activities of STAT3 and Cdk5 in the hypothalamus of obese mice. The hypothalamus of a 5-month-old DIO mouse and a 3-month-old A vy mouse both had higher levels of pSTAT3 (S 727 ) and p25 than their respective controls. The increase of p35 was apparent in DIO but not in the A vy mouse. The housekeeping gene β-actin remained unchanged Figure 6 Overexpression of Cdk5 (wild-type, WT-Cdk5) in SH-SY5Y cells increased leptin-induced pSTAT3 production at 1, 3, and 6 h, whereas DN-Cdk5 (dominant negative without kinase activity) suppressed it at all time points. This was seen for both Y 705 and S727 and did not affect the housekeeping gene β-actin. By contrast, WTCdk5 reduced SOCS-3 at 1 and 3 h but increased it at 6 h Discussion Since the discovery of Cdk5 nearly two decades ago (Hellmich et al. 1992; Meyerson et al. 1992) , much has been revealed about its role in CNS development, migration, synaptic plasticity, pain, addiction, learning, memory, and neurodegenerative disorders. Surprisingly, little attention has been paid to the role of Cdk5 in leptin signaling. Leptin is a hormone that exerts its neuroendocrine effects by multiple signaling pathways downstream to ObR, and many of these may be cell-type specific depending on the co-existence of other receptors (Tu et al. , 2008 . Cdk5 is a ubiquitous kinase in the brain that plays essential roles in CNS development and plasticity, yet it has not been explored whether the Cdk5 system may participate in leptin signaling. In this study, we showed for the first time that the Cdk5 activators p35/p25 kinases can be induced by leptin and in turn provide tight controls of leptin signaling manifested by STAT3 and SOCS-3 activation. This regulatory role of Cdk5/p35/p25 may have broad implications in deciphering the phenomenon of leptin resistance, as seen in many forms of obesity where leptin concentration in the blood is elevated.
We first showed the colocalization of Cdk5 and ObR in the same cells in the hypothalamus (Fig. 1) . This illustrates the biological relevance of the questions. In fact, adultonset obesity is associated with increased level of expression of p35 and p25 kinases (Fig. 7) . Even in HEK293 cells, overexpression of p35 by transient transfection caused a significant increase of STAT3 transcriptional activity (Fig. 2) , indicating that the Cdk5 system is a robust regulator of STAT3 signaling. We then determined leptininduced interactions of Cdk5/p35/p25 and STAT3 in SH-SY5Y neuroblastoma cells because the induction of ObRb in these cells by differentiation and their STAT3 signaling are well documented (Benomar et al. 2005; Jang et al. 2007; Russo et al. 2004) . In these studies, leptin was used at a range of 15-100 nM, and cell differentiation increased the level of ObRb expression (Fig. 3a-c ). This provided a basis for us to choose 30 nM of leptin in our studies.
In differentiated SH-SY5Y cells, leptin activated Cdk5 and its activators p35 and p25 without affecting the housekeeping gene β-actin (Fig. 4) . The only available antibody for p35/p25 recognizes both; nonetheless, the signals corresponding to their respective molecular size indicated that the p25 kinase showed a greater degree of induction. The findings by western blotting are consistent with redistribution of the immunofluorescence of p35/p25 in SH-SY5Y cells treated with leptin for 1 or 6 h. p25 is associated with phosphorylated tau protein and shows a longer half-life as well as wider intracellular distribution than the full-length p35 kinase. Knowing that Cdk5 induces phosphorylation of STAT3 at the S 727 residue, we further determined whether Cdk5 in turn modulates leptin signaling. Although the Cdk5 inhibitor roscovitine affected leptininduced STAT3 activation as anticipated, the patterns of modulation were more complicated than expected and differed at the Y 705 and S 727 sites of pSTAT3. Roscovitine is a commonly used chemical inhibitor of Cdk5 (He et al. 2007; Meijer et al. 1997) . Interestingly, the level of S 727 pSTAT3 in the DMSO vehicle control group showed a transient reduction 10 min after leptin treatment. The exact function of S 727 phosphorylation on STAT3 proteins has been controversial, as an increase, decrease, and absence of change have been reported. Although it is beyond the scope of the current study to determine the interrelationship between Y 705 and S 727 STAT3 activation, the different kinetics of basal activation and differential response to roscovitine suggest separate roles of these two sites. The transient increase of pSTAT3 by roscovitine might be related to inhibition of calcium channels (Yan et al. 2002) .
The long-term potentiating effect of Cdk5 on leptininduced STAT3 activation was further shown by the timedependent increase of pSTAT3 (both Y 705 and S 727 ) in cells overexpressing Cdk5 and by the inhibition of pSTAT3 in cells overexpressing DN-Cdk5. Even in the absence of leptin or other ligands, overexpression of the Cdk5 activator p35 induced dose-related STAT3 transcriptional activity. Since the luciferase reporter assay was performed on HEK293 cells, the lack of effect of Cdk5 and DN-Cdk5 was probably explained by the observation that actively proliferating cells do not have robust Cdk5 activation (Tsai et al. 1993) .
The results show paradoxical activation of SOCS-3 by Cdk5. Roscovitine not only shifted the peak of pSTAT3 activation to earlier times, but also reduced SOCS-3 throughout the study. This suggests a role of Cdk5 in Figure 8 Diagram of the induction and consequences of activation of Cdk5: (1) Leptin signaling through ObRb induces activation of p35, p25, and Cdk5; (2) Cdk5 potentiates the activity of pSTAT3 by enhancing phosphorylation at both Y 705 and S 727 sites; (3) Cdk5 also increases SOCS-3 activity which eventually facilitates termination of STAT3 activation enhancing this prominent negative regulatory pathway to curtail prolonged STAT3 activation after leptin stimulation. Cdk5 is associated with microtubules and implicated in neurodegeneration (Veeranna et al. 2000) . Recently, SOCS-3 has also been shown to participate in cell cycle control by promoting p53-dependent p21 expression that inhibits Cdk activity (Sitko et al. 2008) . SOCS proteins modulate the JAK/STAT pathway by several mechanisms: binding to phosphotyrosines through the SH2 domain and inhibiting signal transduction by N-terminal inactivation of JAK; blocking access of STAT to the receptor sites; or by SOCS box-targeting bound proteins to proteasomal degradation (Larsen and Ropke 2002) . Our finding that Cdk5 acts in conjunction with SOCS-3 further supports the novel dual role of Cdk5 in fine-tuning leptin-induced STAT3 signaling and indicates the convergence of signaling pathways. The interrelationships of these signaling elements are illustrated in Fig. 8 . This is the first study to show that (a) Cdk5 can modulate the activation patterns of leptin-induced pSTAT3 at both Y 705 and S 727 sites and can prolong the resulting activation. (b) Reciprocally, leptin induces Cdk5 activation and increases the protein expression of Cdk5, p35, and p25. (c) While these function to prolong STAT3 activation, Cdk5 also increases SOCS-3 expression at 6 h, thus facilitating the termination of activation. Therefore, we conclude that Cdk5 is a dual player to modulate the long-term effects of leptin.
